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INTRODUCTION 
The Polycystic Ovarian Syndrome manifests itself in 6-
10% women in their reproductive age and is recognized 
as the most common reproductive disorder character-
ized by menstrual irregularity, clinical/biochemical hy-
perandrogenism and polycystic ovaries causing infertili-
ty and affecting females both physically and psychologi-
cally *1+. 
Hyperandrogenism is the important biochemical pa-
rameter of PCOS describing the raised levels of andro-
gen in blood of 80-90% of PCOS patients presenting 
with oligomenorrhea *2-3+. It is thought that elevated 
level of free circulatory testosterone is resulted by the 
increased production of androgen from ovaries due to 
the hyper-secretion of luteinizing hormone (LH) that 
stimulates the ovarian cytochrome p450c17a and ulti-
mately reduces the Sex Hormone Binding Globulin 
(SHBG) synthesized in the liver thus developing the 
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clinical symptoms of hyperandrogenism including hir-
sutism or excess hair growth, acne and frontal bald-
ness. It has been observed that hirsutism is the most 
common presentation of hyperandrogenism occurring 
in 60% of PCOS patients contributing severe depression 
and anxiety in women. Acne is another presenting com-
plaint in 15-30% of females diagnosed with PCOS but 
less specific than hirsutism *4+. 
The popularity of Vitamin D nowadays is undoubtedly 
due to its involvement in the regulation of many physi-
ological processes including immune system, insulin 
secretion, cancer, cell differentiation and reproduction 
through vitamin D receptor (VDR) *5+. 
Hypovitaminosis D has shown a disastrous impact on 
public health worldwide in all age groups. Increased 
prevalence of vitamin D deficiency has been observed 
in South Asian Countries which include India, Pakistan, 
Bangladesh, and Sri Lanka *6+. Two different studies 
from Pakistan have reported the prevalence of vita-
min D deficiency about 70-90% in healthy population 
*7+. Several studies have strongly suggested the role 
of vitamin D in female reproduction by regulating the 
gene expression of aromatase and also found the low 
levels of aromatase in follicles of PCOS females as aro-
matase being an enzyme of granulose cell converts the 
androgen into estrogen demonstrating that de-
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creased level of vitamin D is responsible for the man-
ifestation of hyperandrogenism in PCOS *8+. 
The aim of our study is to find out any association be-
tween severity of hypovitaminosis D and the clinical 
presentation of hyperandrogenism among PCOS pa-
tients . 
MATERIALS AND METHODS  
Study design: Case -control study.  
Ethical Consideration: Written consent was taken 
after explaining the purpose of study. 
Study setting: Study was conducted in Gynecology 
and Obstetrics department of Railway Hospital, Ra-
walpindi in collaboration with Department of Bio-
chemistry IIMC, Rawalpindi. 
Duration of study: 6 months (June 2014 to November 
2014).  
Sample size: Two hundred  
Grouping: Group 1: Females were divided into two 
groups, 100 apparently healthy females had normal 
weight and normal menstrual cycles. None of them 
had clinical symptoms of hyper-andro-genism. 
Group2:  100 newly diagnosed patient of polycystic 
ovarian 
Sampling technique: Non-probability purposive sam-
pling technique was done.  
Inclusion criteria: The females having, the presence of 
two features out of three i.e. polycystic ovarian (PCO) 
morphology on ultrasound scan (presence of 12 or 
more follicles measuring 2- 9  mm  in  diameter  per  
ovary  or  ovarian  volume  above  10cc),  clinical/
biochemical hyperandrogenism (hirsutism, acne or 
alopecia and /or elevated androgens levels) and ovula-
tory dysfunction (oligomenorrhea or amenorrhea) 
were existed. 
Exclusion criteria: The females taking drugs (oral con-
traceptive, hypoglycemic drugs, vitamin D supplemen-
tation) and with other medical causes including Cush-
ing syndrome, androgen secreting tumor, thyroid dis-
orders, and prolectinemia were excluded from the 
research. 
Sampling tools: Ferriman-Gallwey scoring system was 
used to evaluate the hair growth at seven sites: upper 
lip, chin/face, chest, back, abdomen, arms and thighs 
*9+. A score above 8 was indicative of hirsutism. Body 
weight in kilogram and height in meters was measured 
and BMI was calculated as weight (kg) divided by the 
square of the height (m) *10+. 
Biochemical analysis: Three ml venous blood was 
drawn in vaccum clot activator tubes from both groups 
and centrifuged at 2500-3000rpm for 15 minutes for 
serum separation. Serum samples werestored at -20°C 
until further analysis at Biochemistry Research Labora-
tory IIMC *11+. The vitamin D assay was measured by 
Enzyme Linked Immunosorbent Assay by using 25OH 
Vitamin D Total Elisa Kit: Cat#KAP1917; LOT#131106 
(DIA source, SA, B elgium). Hypovitaminosis was de-
fined as plasma level of 25(OH) D less than 30ng/ml, 
graded as severe vitamin D deficiency for plasma level 
of 25(OH) D. 
Statistical analysis: was done in SPSS version 21.0. 
Results were compared by applying independent T test 
and Chi-square. The level of significance was set as 
P<0.05. 
RESULTS 
In this case control study a total of 150 participants 
were included in which there were 100 diagnosed 
patients of PCOS selected according to Rotterdam 
criteria and 50 were healthy normal controls of same 
age group. Vitamin D levels were tested in PCOS pa-
tients presenting clinical features of hyperandrogen-
ism and it is found that there is insignificant relation-
ship present between  severity of hypovitaminosis D 
and  hirsutism (P=0.669), acne (P=0.480) and alopecia 
(P=0.317) among PCOS patients. 
Vitamin D levels were tested in both the groups and 
its values were noted and it was found that the 
mean vitamin D level in control group was 
11.846±7.898 ng/ml and in PCOS group patients the 
mean value of vitamin D level was noted to be 10.618 
±5.296 ng/ml. 
The comparison of vitamin D levels in controls and 
PCOS patients showed that the mean vitamin D level 
was higher in controls (11.846±7.898ng/ml) as com-
pared to PCOS patients (10.618±5.296ng/ml) but this 
was not statistically significantly (P-value > 0.05) differ-
ent in both groups . 
Table 1. Comparison of mean Vitamin D level in     
controls and PCOS patients 
 
The results of comparison of vit D levels between con-
trol group and PCOS group on the basis of different 
weight categories. There was no significant (p-value > 
0.05) difference in mean vitamin D levels when com-
pared in between control and PCOS groups among 
normal weight (12.056±7.742 vs. 11.098±5.318, p-
value = 0.577), over weight (13.024±9.798 vs. 
11.032±6.527, p-value = 0.526) and obese subjects 
(6.307±4.474 vs. 10.354±4.993, p-value = 0.133).  
 
 
Vitamin D 
level  
(ng/ml) 
Group N Mean P-Value 
Control 50 11.846±7.9   
0.324 PCOS 100 10.618±5.3 
Nasim Ilyas et al.  Association of vitamin d deficiency with hyperandrogenism in females with polycystic ovarian syndrome. 
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Table 2: Comparison of Vitamin D levels between   
Control and PCOS group on the basis of different 
weight categories 
 
56% controls and 56% PCOS patients had severe vita-
min D deficiency, 30% controls and 38% PCOS women 
had vitamin D deficiency. Only 1 (2%) woman in con-
trol group had sufficient level of vitamin D. 
 
Figure 1. Vitamin D association with PCOS 
DISCUSSION 
PCOS is one of the most common female endocrine 
disorders with the prevalence of 5-10% in females of 
reproductive age causing infertility, metabolic and 
psychological disturbances leading to decrease quality 
of life *12+. The present study was designed to find out 
the relationship between PCOS and vitamin D and to 
know whether a low vitamin D status is observed in 
unmarried young female of 16-25 years of age with 
PCOS. 
According to the result of our study 56% controls and 
56% PCOS patients had severe vitamin D deficiency 
and the mean value of vitamin D was higher in controls 
(11.846 ±7.898 ng/ml) as compared to PCOS patients 
(10.618±5.296 ng/ml) but the difference was not sta-
tistically significant. So our study could not find any 
association between serum vitamin D and PCOS. Our 
findings are similar to the findings observed by Kim et 
al. who found no differences in the absolute level of 
serum vitamin D between PCOS patients (19.6+6.6 
ng/ml) and   matched controls (20.1±7.4 ng/ml ) and 
p= 0.696 and the prevalence of vitamin D deficiency in 
BMI Vit D PCOS Group P-value 
  N Mean N 
Mean 
Vit D 
  
Normal 
weight 
  
40 
  
12.06±7.74 
  
20 
  
11.10±5.32 
  
0.577 
Over 
weight 
  
7 
  
13.02±9.8 
  
17 
  
11.03±6.527 
  
0.526 
Obese 3 6.31±4.47 63 10.35±4.99 0.133 
controls and patients was 57.9% and 56.5% respective-
ly *11+. 
Panidis at el. reported that vitamin D levels were simi-
lar in women with and without PCOS. These results 
are also in line with our study *11+. Similar findings 
were also found in observational study conducted by 
the Li and colleagues in Scotland in 2011 *13+. The 
results of our study were similar to the study carried 
out by Sahn at el. and Figurova et al. in 2014 and 
2015 respectively *14, 15+. Nine of the reviewed studies 
did not find significant difference between PCOS wom-
en and control groups (overall mean 61.2 nmol/
l=19.24ng/ml in PCOS women vs 67.1nmol/l=21.10ng/
ml in controls) *10+. 
Sirmans  et al. reported lower serum vitamin D level in 
women with PCOS (n=545) compared to control 
(n=145) (25.7 vs 32.0 ng/ml, respectively) *4+. Obser-
vational study conducted in Italy reported lower se-
rum vitamin D level in 90 PCOS women (32.4nmol/
l=10.18ng/ml) than in 40 controls (73.7nmol/
l=23.17ng/ml) *16+. Other two observational studies also 
found significantly lower serum vitamin D level in 
PCOS women compared to control women *17, 18+. 
The study carried out by  Poel et al. even found a sig-
nificantly higher serum vitamin D level in PCOS wom-
en (29.3ng/ml) than in controls (19.4ng/ml) with simi-
lar age and BMI *10+. Although there is discrepancy in 
the literature about the vitamin D levels between 
women with and without PCOS but it is clear that vita-
min D deficiency is a common finding among controls 
and PCOS patients. 
CONCLUSIONS 
This study found no difference in the vitamin D level 
among PCOS and control subjects. Our results are in 
agreement with the previous data supporting an asso-
ciation of BMI with PCOS but don’t support the signifi-
cant association of BMI with severity of hypovitamino-
sis D. 
The limitations in our study are due to small sample 
size, the lack of adjustments of confounding factors 
that may play a role in causing vitamin D deficiency 
and secondly the metabolic features of PCOS were not 
evaluated for comparison with vitamin D level. 
Recommendations: To the best of our knowledge we 
are the first investigating the relationship between vita-
min D deficiency and PCOS in Pakistan. To prove our 
findings new therapeutic approaches and large inter-
vention trials are required.  
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